Zinc picolinate
CAS 17949-65-4
Zinc picolinate (CAS 17949-65-4) is a pharmaceutical compound with 0 bioactivity targets and 18 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Zinc picolinate is linked to DTXSID60170814 in DSSTox identifiers.
View industrial chemical data →Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| ZINC PICOLINATE | 58301 | SU | MTHSPL |
| zinc picolinate | 58301 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Zinc picolinate used for in pharmaceutical contexts?
Zinc picolinate (CAS 17949-65-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Zinc picolinate?
Zinc picolinate has 18 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Coronavirus infection, Cytopenia, Dyspepsia, Eye irritation, Fatigue. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Zinc picolinate also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for ZINC PICOLINATE with EU status "restricted".
What clinical phase is Zinc picolinate in?
No phase 1-4 clinical development badge is rendered for Zinc picolinate because the matched compound identifier rows do not contain a max-phase value.